BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37742878)

  • 1. The role of Ginkgo Folium on antitumor: Bioactive constituents and the potential mechanism.
    Hu D; Wang HJ; Yu LH; Guan ZR; Jiang YP; Hu JH; Yan YX; Zhou ZH; Lou JS
    J Ethnopharmacol; 2024 Mar; 321():117202. PubMed ID: 37742878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VERIFICATION OF AUTHENTICITY OF
    Budeč M; Bošnir J; Racz A; Lasić D; Brkić D; Mosović Ćuić A; Kuharić Ž; Jurak G; Barušić L
    Acta Clin Croat; 2019 Dec; 58(4):672-692. PubMed ID: 32595253
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective responses of three Ginkgo biloba leaf-derived constituents on human intestinal bacteria.
    Lee HS; Kim MJ
    J Agric Food Chem; 2002 Mar; 50(7):1840-4. PubMed ID: 11902921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves.
    Sloley BD; Urichuk LJ; Morley P; Durkin J; Shan JJ; Pang PK; Coutts RT
    J Pharm Pharmacol; 2000 Apr; 52(4):451-9. PubMed ID: 10813558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic evaluation of Ginkgo biloba leaf extract-induced genotoxicity in L5178Y cells.
    Lin H; Guo X; Zhang S; Dial SL; Guo L; Manjanatha MG; Moore MM; Mei N
    Toxicol Sci; 2014 Jun; 139(2):338-49. PubMed ID: 24595819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of cytochrome P450s by terpene trilactones and flavonoids of the Ginkgo biloba extract EGb 761 in rats.
    Deng Y; Bi HC; Zhao LZ; He F; Liu YQ; Yu JJ; Ou ZM; Ding L; Chen X; Huang ZY; Huang M; Zhou SF
    Xenobiotica; 2008 May; 38(5):465-81. PubMed ID: 18421621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGb 761: ginkgo biloba extract, Ginkor.
    Drugs R D; 2003; 4(3):188-93. PubMed ID: 12757407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncovering the anti-obesity constituents in Ginkgo biloba extract and deciphering their synergistic effects.
    Zhang M; Hou XD; Liu W; Wang L; Jiang MF; Hou J; Tang H; Ge GB
    Fitoterapia; 2023 Dec; 171():105669. PubMed ID: 37683877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leaves, seeds and exocarp of Ginkgo biloba L. (Ginkgoaceae): A Comprehensive Review of Traditional Uses, phytochemistry, pharmacology, resource utilization and toxicity.
    Liu Y; Xin H; Zhang Y; Che F; Shen N; Cui Y
    J Ethnopharmacol; 2022 Nov; 298():115645. PubMed ID: 35988840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginkgoghrelins, unique acylated flavonoid diglycosides in Folium Ginkgo, stimulate growth hormone secretion via activation of the ghrelin receptor.
    Hsieh SK; Chung TY; Li YC; Lo YH; Lin NH; Kuo PC; Chen WY; Tzen JT
    J Ethnopharmacol; 2016 Dec; 193():237-247. PubMed ID: 27523747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative vasodilating actions among terpenoids and flavonoids contained in Ginkgo biloba extract.
    Nishida S; Satoh H
    Clin Chim Acta; 2004 Jan; 339(1-2):129-33. PubMed ID: 14687903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a gas chromatographic-mass spectrometric method for simultaneous identification and quantification of marker compounds including bilobalide, ginkgolides and flavonoids in Ginkgo biloba L. extract and pharmaceutical preparations.
    Deng F; Zito SW
    J Chromatogr A; 2003 Jan; 986(1):121-7. PubMed ID: 12585329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of intestinal and hepatic glucuronidation of mycophenolic acid by Ginkgo biloba extract and flavonoids.
    Mohamed MF; Frye RF
    Drug Metab Dispos; 2010 Feb; 38(2):270-5. PubMed ID: 19889883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective Mechanism and Active Compounds of
    Sun X; Zhu Y; Li F; Li M; Wan G
    Comput Math Methods Med; 2022; 2022():4338260. PubMed ID: 36213575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
    Chang TK; Chen J; Yeung EY
    Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells.
    Kang JW; Kim JH; Song K; Kim SH; Yoon JH; Kim KS
    Phytother Res; 2010 Jan; 24 Suppl 1():S77-82. PubMed ID: 19585476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insight into the mechanisms of Ginkgo biloba leaves in the treatment of cancer.
    Yu J; Wang J; Yang J; Ouyang T; Gao H; Kan H; Yang Y
    Phytomedicine; 2024 Jan; 122():155088. PubMed ID: 37844377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex quantitation of 17 drug-derived components in human plasma after administration of a fixed herbal preparation of Sailuotong using combined online SPE-LC-MS/MS methods.
    Zhang Y; Guo C; Liu H; Yang L; Ren C; Li T; Liu J
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115843. PubMed ID: 36265676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Ginkgo biloba extract on rat hepatic microsomal CYP1A activity: role of ginkgolides, bilobalide, and flavonols.
    Kuo If; Chen J; Chang TK
    Can J Physiol Pharmacol; 2004 Jan; 82(1):57-64. PubMed ID: 15052306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic herb-disease-drug interactions: Effect of ginkgo biloba extract on the pharmacokinetics of pitavastatin, a substrate of Oatp1b2, in rats with non-alcoholic fatty liver disease.
    Li Z; Tian S; Wu Z; Xu X; Lei L; Li Y; Wang B; Huang Y
    J Ethnopharmacol; 2021 Nov; 280():114469. PubMed ID: 34329714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.